SUMMARY BackgroundOne-third of patients with Crohn's disease (CD) or ulcerative colitis (UC) receiving anti-TNFs do not respond to treatment, and a relevant proportion experience loss of response or intolerance.

No abstract

Fecal calprotectin and lactoferrin determination may be useful in predicting impending clinical relapse-especially during the following 3 months-in both CD and UC patients.

SUMMARY BackgroundThe decreasing efficacy of H. pylori eradication treatments over time makes the search for better regimens and adjuvant medications a priority.